Nicholas Investment Partners, LP Guardant Health, Inc. Transaction History

Nicholas Investment Partners, LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$28.82 - $77.35 $4.91 Million - $13.2 Million	-170,198 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$48.25 - $100.49 $2.8 Million - $5.83 Million	57,985 Added 51.67%	170,198 $11.3 Million
Q4 2021 Feb 14, 2022	BUY	$88.71 - $120.43 $1.58 Million - $2.15 Million	17,850 Added 18.92%	112,213 $11.2 Million
Q3 2021 Nov 15, 2021	SELL	$98.77 - $132.17 $3.25 Million - $4.34 Million	-32,860 Reduced 25.83%	94,363 $11.8 Million
Q2 2021 Aug 10, 2021	SELL	$109.77 - $165.68 $2.99 Million - $4.52 Million	-27,284 Reduced 17.66%	127,223 $15.8 Million
Q1 2021 May 14, 2021	BUY	$127.04 - $179.1 $312,391 - $440,406	2,459 Added 1.62%	154,507 $23.6 Million
Q4 2020 Feb 11, 2021	BUY	$99.96 - $135.93 $1.39 Million - $1.9 Million	13,948 Added 10.1%	152,048 $19.6 Million
Q3 2020 Nov 13, 2020	BUY	$80.32 - $111.8 $9.81 Million - $13.7 Million	122,113 Added 763.83%	138,100 $15.4 Million
Q2 2020 Aug 12, 2020	SELL	$60.49 - $97.5 $1.61 Million - $2.59 Million	-26,609 Reduced 62.47%	15,987 $1.3 Million
Q1 2020 May 13, 2020	BUY	$59.04 - $88.81 $21,136 - $31,793	358 Added 0.85%	42,596 $2.97 Million
Q4 2019 Feb 13, 2020	SELL	$59.49 - $82.78 $3.06 Million - $4.26 Million	-51,434 Reduced 54.91%	42,238 $3.3 Million
Q3 2019 Nov 13, 2019	SELL	$62.59 - $110.3 $15,271 - $26,913	-244 Reduced 0.26%	93,672 $5.98 Million
Q2 2019 Aug 09, 2019	BUY	$63.94 - $91.11 $6 Million - $8.56 Million	93,916 New	93,916 $8.11 Million

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.24B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Nicholas Investment Partners, LP with notifications on news.